查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球面部美容市场 - 2023-2030
市场调查报告书
商品编码
1347965

全球面部美容市场 - 2023-2030

Global Facial Aesthetics Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2022年，全球面部美容市场规模达到65亿美元，预计到2030年将达到193亿美元，2023-2030年预测期间复合年增长率为9.1%。

面部美容是一种非手术和微创手术，可以暂时减少皱纹或恢復皱纹。常见的治疗区域包括前额、脸颊和嘴唇。产品推出的增加和麵部手术需求的增加是市场的驱动因素。

预计北美地区将在市场份额中占据重要地位。手术数量和产品发布数量的增加使该地区占据了主导地位。

面部美容市场研究分析提供了包含定量和定性数据的市场深入展望。它根据市场细分对全球市场进行了展望和预测。

动力学

产品发布数量的增加正在推动市场增长

产品发布数量的增加正在推动市场增长。例如，2023 年 1 月 17 日，艾伯维 (AbbVie) 旗下公司 Allergan Aesthetics 推出了期待已久的 SkinMedica Even & Correct 系列。这些先进的美白护理产品、黑斑霜和美白治疗垫经过临床验证，其配方可提供有针对性的效果，可单独或共同发挥作用，均匀肤色，减少面部色素沉着和黑斑的出现。

此外，2023 年 1 月 10 日，总部位于孟买的 ENTOD Pharmaceuticals 推出了新的眼科美容系列，专注于改善眼睛舒适度并增强眼睛的美观。这些产品已以 Eyecirque、Lashfactor 和 Vasuki 品牌推出。 Eyecirque 系列包括世界上第一个基于纳米技术的凝胶精华液、眼下皮肤提亮和抗衰老片剂、润滑滴眼液和基本眼部补充剂。因此，产品推出的增加将加速市场增长。

关键参与者对面部美容手术和策略的需求不断增加将推动市场增长

对面部美容手术的需求增加增加了产品的推出，从而推动了市场的增长。例如，2023 年 1 月 9 日，国际美容整形外科学会 (ISAPS) 发布了其年度全球美容/整容手术调查结果，显示 2021 年整形外科医生实施的手术总体增加了 19.3%，其中更多全球范围内实施了超过1,280 万例外科手术和1,750 万例非外科手术。

这些公司製定的战略，如合作、伙伴关係等，预计将推动市场增长。例如，2021 年 1 月 15 日，全球医学美容领域的领导者 Merz Aesthetics 与美容器械公司 Candela Corporation 启动了商业合作，为全球消费者提供广泛的医学美容产品组合。

此外，2022 年 5 月 24 日，全球领先的全面一体化护肤公司 Crown Laboratories 收购了其全球专注于美容的资产。此次收购扩大了 Crown 的美容产品组合，并增强了 Crown 作为基于科学的美容护肤解决方案全球领导者的整体价值主张。因此，上述因素预计将推动市场增长。

产品和治疗的高成本预计将阻碍市场增长

这些面部美容手术价格昂贵，高成本成为市场增长的障碍。例如，根据美国整形外科医生协会的最新统计数据，整容的平均费用为 8,005 美元。外科医生收取的费用是决定整体治疗费用的关键因素之一。除了外科医生之外，麻醉师的费用也增加了治疗费用。根据程序的复杂性和要求，成本会增加。因此，它成为市场增长的製约因素。

目录

第 1 章：方法和范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章：定义和概述

第 3 章：执行摘要

  • 按产品分类的片段
  • 按应用程序片段
  • 最终用户的片段
  • 按地区分類的片段

第 4 章：动力学

  • 影响因素
    • 司机
      • 产品发布数量增加
      • 关键参与者对面部美容程序和策略的需求不断增加
    • 限制
      • 产品和治疗成本高
    • 机会
    • 影响分析

第 5 章：行业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 俄乌战争影响分析
  • DMI 意见

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商战略倡议
  • 结论

第 7 章：副产品

  • 真皮填充剂
  • 肉毒桿菌毒素
  • 化学换肤术
  • 微晶磨皮术

第 8 章：按应用

  • 面部线条矫正治疗
  • 疤痕治疗
  • 唇部护理
  • 恢復体积/丰满度
  • 其他的

第 9 章：最终用户

  • 医院
  • 专科诊所
  • 皮肤科诊所
  • 其他的

第 10 章：按地区

  • 北美
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章：公司简介

第 13 章：高德美控股 SA *

    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • 梅尔兹製药有限责任公司
  • 苏内瓦医疗
  • 科曼博士实验室有限公司
  • 辛克莱製药公司
  • 四恶烷
  • 华熙生物
  • 强生医疗科技
  • 索尔塔医疗
  • 指娱天地有限公司

第 14 章：附录

简介目录
Product Code: MD2244

Overview

Global Facial Aesthetics Market reached US$ 6.5 billion in 2022 and is expected to reach US$ 19.3 billion by 2030, growing with a CAGR of 9.1% during the forecast period 2023-2030.

Facial aesthetics are a non-surgical and minimally invasive procedure that can temporarily diminish wrinkles or restore volume. Common treatment areas include the forehead, cheeks, and lips. An increase in product launches and an increase in the demand for facial surgeries are driving factors for the market.

The North America region is expected to hold a significant position in the market share. The increase in the number of procedures and product launches is holding the region in the dominant share.

Facial Aesthetics Market study analysis offers an in-depth outlook on the market containing quantitative and qualitative data. It gives an outlook and forecast of the global market based on market segmentation.

Dynamics

Increase in the Number of Product Launches is Driving the Market Growth

The increase in the number of product launches is driving the market growth. For instance, on January 17, 2023, Allergan Aesthetics, an AbbVie company, launched the long-awaited SkinMedica Even & Correct Collection. Clinically proven and formulated to deliver targeted results, these advanced brightening treatments, dark spot creams, and brightening treatment pads work separately and together to even skin tone and reduce the appearance of hyperpigmentation and dark spots on the face.

Additionally, on January 10, 2023, Mumbai-based ENTOD Pharmaceuticals launched its new ocular aesthetic range focused on improving eye comfort and enhancing the aesthetics of the eyes. The products have been launched under the Eyecirque, Lashfactor, and Vasuki brands. The Eyecirque range comprises the world's first nanotechnology-based gel serum, under-eye skin brightening and anti-aging tablets, lubricating eye drops, and essential eye supplements. Thus, an increase in product launches will accelerate the market growth.

Increasing Demands for Facial Aesthetic Procedures and Strategies by the Key Players will Drive Market Growth

The increase in the demand for facial aesthetic procedures increases the product launches, which are driving the market growth. For instance, on January 9, 2023, the International Society of Aesthetic Plastic Surgery (ISAPS) released the results of its annual global survey on Aesthetic/Cosmetic Procedures, showing a 19.3% overall increase in procedures performed by plastic surgeons in 2021, with more than 12.8 million surgical, and 17.5 million non-surgical, procedures performed worldwide.

The strategies developed by the companies, such as collaborations, partnerships, and others, are expected to drive market growth. For instance, on January 15, 2021, Merz Aesthetics, the world leader in medical aesthetics, and Candela Corporation, an aesthetic device company, launched a commercial collaboration to provide a broad medical aesthetics portfolio to consumers across the globe.

Additionally, May 24, 2022, Crown Laboratories, a leading, fully integrated global skincare company, has acquired its global aesthetics-focused assets. The acquisition expands Crown's aesthetics product portfolio and enhances Crown's overall value proposition as a global leader in science-based aesthetic skincare solutions. Thus, the above factors are expected to drive the market growth.

High Cost of the Products and Treatments are Expected to Hamper the Market Growth

These facial aesthetic procedures are expensive, and the high cost becomes a barrier to market growth. For instance, according to the American Society of Plastic Surgeons, The average cost of a facelift is $8,005, according to the most recent statistics from the American Society of Plastic Surgeons. The fee charged by the surgeon is one of the key factors determining the overall treatment cost. Besides the surgeon, the anesthetist's fee also adds to the treatment cost. Depending on the complexity and requirements of the procedure, the cost increases. Thus, it acts as a restraining factor for the market growth.

Segment Analysis

The global facial aesthetics market is segmented based on product, application, end-user, and region.

Derma Fillers Segment is Expected to Hold the Largest Market Share in the Global Facial Aesthetics Market

The derma fillers segment holds a significant share in the global facial aesthetics market. The increase in the number of FDA approvals of the products drives the segment growth. For instance, on May 19, 2023, Sculptra Aesthetic, the first poly-L-lactic acid (PLLA) Derma filler used to restore natural-looking facial volume, was recently granted FDA approval to treat fine lines and wrinkles throughout the cheek area.

Additionally, on May 15, 2023, Allergan Aesthetics, an AbbVie company, announced the U.S. FDA approval of SKINVIVE by JUVEDERM to improve skin smoothness of the cheeks in adults over the age of 21. SKINVIVE by JUVEDERM is the first and only hyaluronic acid (HA) intraDerma microdroplet injection for skin smoothness available in the U.S., with results lasting through six months with optimal treatment. Thus, the increased product approvals are holding the segment in the dominant position in the market share.

Geographical Penetration

North America is Expected to Hold a Significant Position in the Global Facial Aesthetics Market Share

North America is a dominant force in the global facial aesthetics market share. With the increase in the demand for facial surgeries, there is an increase in the number of launches of treatment procedures. For instance, according to ClevelandClinic Organization it is estimated that every year, providers perform more than 15 million cosmetic surgery procedures in the United States. More than 13 million of those are minimally invasive procedures.

Additionally increase in the demand for surgeries increases the launch of the products. For instance, on August 18, 2023, Movel Medical Aesthetics, a state-of-the-art and unique mobile Med Spa for facial aesthetics introduced the revolutionary Fotona 4D, Eyelase, and LipLase procedures to its service offering for patients. Thus, the above factors are holding the region in the dominant position of the market share.

COVID-19 Impact Analysis

COVID-19 has impacted the growth of the facial aesthetics market. There are a number of individuals who frequently approach clinics and facial aesthetics centers for surgeries. Due to the pandemic, the clinics were shut down. Having most facial aesthetics surgery cases as elective operations, plastic and aesthetic surgery became one of the branches most affected by the pandemic process.

A drastic decline was experienced in the number of plastic surgeries. The stringent rules and regulations have impacted the market growth. The implementation of lockdown has restricted people from visiting the clinics and continuing the treatment process. The restrictions helped in preventing the spread of the virus. However, there was an increase in demand that occurred in the period after the restrictions.

By Product

  • Derma Fillers
  • Botulinum Toxin
  • Chemical Peel
  • Microdermabrasion

By Application

  • Facial Line Correction Treatment
  • Scar Treatment
  • Lip Treatments
  • Restoration of Volume/ Fullness
  • Others

By End-User

  • Hospitals
  • Specialty Clinics
  • Dermatology Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The global facial aesthetics market is fragmented, with the presence of many local and international players. Galderma Holding SA, Merz Pharmaceuticals, LLC, Suneva Medical, Dr. Korman Laboratories Ltd., Sinclair Pharma, Teoxane, Bloomage Biotech, Johnson & Johnson MedTech, Solta Medical, and Cynosure LLC are the leading companies with a significant market share.

Why Purchase the Report?

  • To visualize the global facial aesthetics market segmentation based on product, application, end-user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of facial aesthetics market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global facial aesthetics market report would provide approximately 61 tables, 58 figures, and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increase in the number of product launches
      • 4.1.1.2. Increasing demands for facial aesthetic procedures and strategies by the key players
    • 4.1.2. Restraints
      • 4.1.2.1. High cost of the products and treatments
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Derma Fillers *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Botulinum Toxin
  • 7.4. Chemical Peel
  • 7.5. Microdermabrasion

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Facial Line Correction Treatment *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Scar Treatment
  • 8.4. Lip Treatments
  • 8.5. Restoration of Volume/ Fullness
  • 8.6. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Dermatology Clinics
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

13. Galderma Holding SA *

    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Merz Pharmaceuticals, LLC
  • 13.3. Suneva Medical
  • 13.4. Dr. Korman Laboratories Ltd.
  • 13.5. Sinclair Pharma
  • 13.6. Teoxane
  • 13.7. Bloomage Biotech
  • 13.8. Johnson & Johnson MedTech
  • 13.9. Solta Medical
  • 13.10. Cynosure LLC

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us